Fri, Aug 1, 2014, 6:34 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Zalicus Inc. Message Board

  • benimblebequick1 benimblebequick1 Apr 3, 2013 11:39 AM Flag

    novartis renews contract


    Zalicus Provides Oncology Research Collaboration Update
    CAMBRIDGE, Mass., Apr 26, 2012 (BUSINESS WIRE) --Zalicus Inc. (NASDAQ: ZLCS) provided an update today on its research collaboration with Novartis, based on its combination High Throughput Screening (cHTS) platform.
    Based on the success of the collaboration up to this point, Novartis has exercised its second option to extend its oncology discovery research collaboration with Zalicus for an additional contract year, through April 2013.
    "The extension of our alliance with Novartis confirms the value of the cHTS discovery technology to the advancement of novel treatments for cancer," commented Mark H.N. Corrigan, MD, President and CEO of Zalicus.

    FROM 2012

    This topic is deleted.
1.180.00(0.00%)Jul 15 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.